A Randomised, controlled trial to evaluate the safety and efficacy of oral rivaroxaban compared with the conservative treatment in patients with femoral neck fracture
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis
- Focus Adverse reactions; Therapeutic Use
- 28 Aug 2017 New trial record
- 01 Jul 2017 Primary endpoint (Venous thromboembolism (VTE) defined as deep vein thrombosis (DVT) or pulmonary embolism (PE).) has been met, according to the results published in the Medicine
- 01 Jul 2017 Results published in the Medicine